Tel Aviv, Israel

Ron Schlinger

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Tel Aviv, IL (2019 - 2023)
  • Haifa, IL (2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Ron Schlinger**

Introduction

Ron Schlinger, an accomplished inventor based in Tel Aviv, Israel, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 11 patents, his innovative spirit continues to drive advancements in topical formulations.

Latest Patents

Among his latest contributions, Schlinger has developed topical Montelukast formulations. These formulations include a topical emulsion containing about 0.5% to about 10% Montelukast or its pharmaceutically acceptable salts, combined with about 0.4% to about 4% carbomer. Notably, the particles comprising Montelukast in the emulsion achieve a D90 of less than 50 μm, ensuring a homogenous dispersion within a pH range of about 3.0 to about 6.5. Additionally, his patents detail a topical gel formulation consisting of about 0.5% to about 10% Montelukast, approximately 0.2% to about 8% cellulose polymer, and a significant portion (about 80% to about 95%) of amphiphilic compounds, with less than 4% water content.

Career Highlights

Schlinger has had a dynamic career with notable stints in established pharmaceutical companies, including Taro Pharmaceutical Industries Limited and Dexcel Pharma Technologies Ltd. His work in these organizations has profoundly shaped his research and development approach, making him a significant player in the pharmaceutical industry.

Collaborations

Throughout his career, Schlinger has collaborated with several esteemed professionals, including Avi Avramoff and Helena Shifrin. These collaborations have contributed to his innovative developments, allowing for a fusion of ideas that enhance the effectiveness of his inventions.

Conclusion

Ron Schlinger stands out as an influential inventor whose contributions to topical formulations have the potential to improve patient care significantly. With a robust patent portfolio and collaborations with talented professionals, his future endeavors are eagerly anticipated within the pharmaceutical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…